Variant report
Variant | esv3411546 |
---|---|
Chromosome Location | chr8:20376572-20380970 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs569360008 | chr8:20376583-20376584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75365422 | chr8:20376586-20376587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569864491 | chr8:20376600-20376601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs71512766 | chr8:20376692-20376693 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs538497883 | chr8:20376745-20376746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534017425 | chr8:20376754-20376755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs17092700 | chr8:20376761-20376762 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs79659585 | chr8:20376792-20376793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs17092702 | chr8:20376797-20376798 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs556596725 | chr8:20376802-20376803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373630279 | chr8:20376807-20376808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192854916 | chr8:20376858-20376859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560864925 | chr8:20376861-20376862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369013180 | chr8:20376877-20376878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143076297 | chr8:20376897-20376898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564927728 | chr8:20376918-20376919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532222285 | chr8:20376953-20376954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550735400 | chr8:20377044-20377045 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562666722 | chr8:20377078-20377079 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs148230236 | chr8:20377082-20377083 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs17092704 | chr8:20377092-20377093 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs184777692 | chr8:20377131-20377132 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566534950 | chr8:20377137-20377138 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552914075 | chr8:20377165-20377166 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571229451 | chr8:20377295-20377296 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs533884463 | chr8:20377311-20377312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188505512 | chr8:20377355-20377356 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570580414 | chr8:20377372-20377373 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs111598823 | chr8:20377392-20377393 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538943695 | chr8:20377395-20377396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556697277 | chr8:20377398-20377399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141140575 | chr8:20377412-20377413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536138561 | chr8:20377420-20377421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192985199 | chr8:20377426-20377427 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150727003 | chr8:20377463-20377464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs140163896 | chr8:20377466-20377467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs184697657 | chr8:20377481-20377482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs80060023 | chr8:20377523-20377524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73218493 | chr8:20377537-20377538 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs544123992 | chr8:20377554-20377555 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562692561 | chr8:20377555-20377556 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs13265631 | chr8:20377560-20377561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs111787656 | chr8:20377583-20377584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529807674 | chr8:20377636-20377637 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs74338525 | chr8:20377660-20377661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117244776 | chr8:20377661-20377662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113641060 | chr8:20377689-20377690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs573317996 | chr8:20377702-20377703 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112386445 | chr8:20377747-20377748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs17092705 | chr8:20377795-20377796 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Melanoma | 20688739 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:20367400-20377000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:20375400-20377000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
3 | chr8:20375400-20377200 | Weak transcription | Primary hematopoietic stem cells | blood |
4 | chr8:20375800-20377400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr8:20375800-20377400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr8:20377000-20377200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr8:20377000-20378000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
8 | chr8:20377200-20377800 | Enhancers | Primary hematopoietic stem cells | blood |
9 | chr8:20377200-20379600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr8:20377400-20377800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr8:20377400-20378200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr8:20379200-20379400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr8:20379600-20379800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr8:20379800-20380000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |